---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-088238"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-17T07:38:43.794840+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics appoints Roger Dansey and Hervé Hoppenot to Board of Directors

## Summary
- Roger Dansey, M.D. (ex-Pfizer/Seagen) and Hervé Hoppenot (ex-Incyte/Novartis) joined the board effective Sep 8, 2025.
- Board expanded from 8 to 10 members; Dr. Dansey serves as Class III director, Mr. Hoppenot as Class I director.
- Both are independent; Dr. Dansey will serve on Scientific and Nominating/Governance committees, Mr. Hoppenot on Audit and Compensation.

## SEC filing metadata
- accession: 0001104659-25-088238
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465925088238/0001104659-25-088238-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465925088238/tm2525491d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-088238
- JSON: https://secwatch.observer/filing/0001104659-25-088238.json
- Plain text: https://secwatch.observer/filing/0001104659-25-088238.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.